TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Thermo Fisher ( (TMO) ) just unveiled an update.
On December 1, 2025, Thermo Fisher Scientific’s subsidiary, Thermo Fisher International, issued €2.1 billion in senior notes through a public offering. The proceeds from this issuance are intended for general corporate purposes, potentially including acquisitions, debt repayment, and capital expenditures, reflecting the company’s strategic financial management and positioning in the market.
The most recent analyst rating on (TMO) stock is a Buy with a $670.00 price target. To see the full list of analyst forecasts on Thermo Fisher stock, see the TMO Stock Forecast page.
Spark’s Take on TMO Stock
According to Spark, TipRanks’ AI Analyst, TMO is a Outperform.
Thermo Fisher’s strong financial performance and positive earnings call are the most significant factors driving the score. The company’s robust profitability and strategic initiatives, such as collaborations and acquisitions, support its growth outlook. However, technical indicators suggest the stock may be overbought, and the high P/E ratio indicates potential overvaluation, which tempers the overall score.
To see Spark’s full report on TMO stock, click here.
More about Thermo Fisher
Thermo Fisher Scientific is a prominent company in the scientific industry, providing a wide range of products and services, including laboratory equipment, analytical instruments, reagents, and consumables. The company focuses on serving healthcare, life sciences, and industrial sectors, aiming to support scientific research and innovation.
Average Trading Volume: 2,033,586
Technical Sentiment Signal: Buy
Current Market Cap: $222B
See more insights into TMO stock on TipRanks’ Stock Analysis page.